115 related articles for article (PubMed ID: 16201499)
1. [Analysis of gene expression profiles in malignant brain tumors with respect to sensitivity to therapies].
Yamanaka R; Morii K; Takahashi H; Tanaka R; Nishio K
Nihon Rinsho; 2005 Sep; 63 Suppl 9():49-54. PubMed ID: 16201499
[No Abstract] [Full Text] [Related]
2. [Gene expression profiling of malignant gliomas by cDNA microarrays].
Takahashi H; Kouno J
Nihon Rinsho; 2005 Sep; 63 Suppl 9():515-9. PubMed ID: 16201574
[No Abstract] [Full Text] [Related]
3. [Molecular biology of brain tumors].
Tamiya T; Morisaki K; Miyake K; Matsumoto Y; Nagao S; Daido S; Ichikawa T
Nihon Rinsho; 2005 Sep; 63 Suppl 9():30-4. PubMed ID: 16201496
[No Abstract] [Full Text] [Related]
4. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL
Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714
[TBL] [Abstract][Full Text] [Related]
5. [Chemotherapy for gliomas based on the expression levels of drug resistant genes].
Matsumoto Y; Morisaki K; Miyake K; Kawanishi M; Kawai N; Ogawa T; Irie K; Kunishio K; Nagao S
No Shinkei Geka; 2001 Jul; 29(7):625-30. PubMed ID: 11517503
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of O6-methylguanine-DNA methyltransferase gene expression in gliomas by platinum compounds.
Tanaka S; Kobayashi I; Utsuki S; Oka H; Yasui Y; Fujii K
Oncol Rep; 2005 Nov; 14(5):1275-80. PubMed ID: 16211296
[TBL] [Abstract][Full Text] [Related]
7. Lymphoid gene expression as a predictor of risk of secondary brain tumors.
Edick MJ; Cheng C; Yang W; Cheok M; Wilkinson MR; Pei D; Evans WE; Kun LE; Pui CH; Relling MV
Genes Chromosomes Cancer; 2005 Feb; 42(2):107-16. PubMed ID: 15543619
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenomics of brain cancer and personalized medicine in malignant gliomas.
Shai RM; Reichardt JK; Chen TC
Future Oncol; 2008 Aug; 4(4):525-34. PubMed ID: 18684063
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy for low-grade gliomas: emerging consensus on its benefits.
Wen PY; DeAngelis LM
Neurology; 2007 May; 68(21):1762-3. PubMed ID: 17515537
[No Abstract] [Full Text] [Related]
10. New treatment strategies for malignant gliomas.
Sathornsumetee S; Rich JN
Expert Rev Anticancer Ther; 2006 Jul; 6(7):1087-104. PubMed ID: 16831080
[TBL] [Abstract][Full Text] [Related]
11. A cDNA-microarray analysis of camptothecin resistance in glioblastoma cell lines.
Morandi E; Zingaretti C; Chiozzotto D; Severini C; Semeria A; Horn W; Vaccari M; Serra R; Silingardi P; Colacci A
Cancer Lett; 2006 Jan; 231(1):74-86. PubMed ID: 16356833
[TBL] [Abstract][Full Text] [Related]
12. [Genetic analysis and individualized therapy for diffuse glioma].
Watanabe T; Yoshino A; Katayama Y
No Shinkei Geka; 2005 Jun; 33(6):537-53. PubMed ID: 15952303
[No Abstract] [Full Text] [Related]
13. Malignant brain tumors: two steps forward.
Puget S; Rutka JT
Clin Neurosurg; 2007; 54():4-9. PubMed ID: 18504889
[No Abstract] [Full Text] [Related]
14. [Individualized therapy for glioma].
Okada Y; Ueki K
Nihon Rinsho; 2005 Sep; 63 Suppl 9():288-92. PubMed ID: 16201536
[No Abstract] [Full Text] [Related]
15. High-grade glioma: can we teach an old dogma new tricks?
Gilbertson RJ
Cancer Cell; 2006 Mar; 9(3):147-8. PubMed ID: 16530697
[TBL] [Abstract][Full Text] [Related]
16. Molecular cloning and characterization of a novel human BTB domain-containing gene, BTBD10, which is down-regulated in glioma.
Chen J; Xu J; Ying K; Cao G; Hu G; Wang L; Luo C; Lou M; Mao Y; Xie Y; Lu Y
Gene; 2004 Sep; 340(1):61-9. PubMed ID: 15556295
[TBL] [Abstract][Full Text] [Related]
17. Robustness of gene expression profiling in glioma specimen samplings and derived cell lines.
Mehrian Shai R; Reichardt JK; Ya-Hsuan H; Kremen TJ; Liau LM; Cloughesy TF; Mischel PS; Nelson SF
Brain Res Mol Brain Res; 2005 May; 136(1-2):99-103. PubMed ID: 15893592
[TBL] [Abstract][Full Text] [Related]
18. [Report of two cases with germinoma treated by individual adjuvant chemotherapy based on the mRNA expression of drug-resistance gene].
Kunishio K; Okada M; Miyake K; Matsumoto Y; Nagao S; Nishiyama Y; Ohkawa M
No Shinkei Geka; 2004 Jan; 32(1):19-26. PubMed ID: 14978920
[TBL] [Abstract][Full Text] [Related]
19. Therapy for recurrent malignant glioma in adults.
Mrugala MM; Kesari S; Ramakrishna N; Wen PY
Expert Rev Anticancer Ther; 2004 Oct; 4(5):759-82. PubMed ID: 15485312
[TBL] [Abstract][Full Text] [Related]
20. Adenoviral transfer of antisenses or ribozyme to O6-methylguanine-DNA methyltransferase mRNA in brain-tumor model resistant to chloroethyl-nitrosourea.
Manome Y; Yoshinaga H; Watanabe M; Ohno T
Anticancer Res; 2002; 22(4):2029-36. PubMed ID: 12174880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
